A test found that the selective serotonin reuptake inhibitor
citalopram did not relieve symptoms of repetitive behavior or
movement in children with autism spectrum disorders.
To continue reading this article, you must login
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.